Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International

Wikipedia Affiliate Button

Home > News > Nanoparticle Offers Early-Stage Treatment to Brain Injuries

August 30th, 2012

Nanoparticle Offers Early-Stage Treatment to Brain Injuries

Abstract:
Researchers at Rice University are reporting success in using a nanoparticle as an emergency treatment for traumatic brain injuries. The research could also improve brain injury treatment for stroke victims and organ transplant patients.

The nanoparticle, which was developed at Rice University, is polyethylene glycol-hydrophilic carbon clusters (PEG-HCC). It's already being tested in cancer treatment, where it has shown itself to be a powerful antioxidant.

In the current research, the Rice team took PEG-HCC's effectiveness as an antioxidant one step further, by using it to counter something called reactive oxygen species (ROS)—after a traumatic brain injury, cells release an excessive amount of an ROS called superoxide (SO) into the blood.

Source:
spectrum.ieee.org

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Drilling speed increased by 20% – yet another upgrade in the oil & gas sector made possible by graphene nanotubes January 15th, 2019

Chirality in 'real-time' January 14th, 2019

New materials could help improve the performance of perovskite solar cells January 11th, 2019

Media invited to open meeting on the future of quantum technology held at RIT Jan. 23-25: Leaders from NASA, NSF, NIST and Sandia National Laboratory to attend January 11th, 2019

Blog sites

Novel Electrode Structure Provides New Promise for Lithium-Sulfur Batteries December 3rd, 2016

Peter Diamandis Thinks Nanotech Will Interface With Human Minds September 1st, 2016

Graphene-Enabled Paper Makes for Flexible Display August 1st, 2016

Marrying superconductors, lasers, and Bose-Einstein condensates: Chapman University Institute for Quantum Studies (IQS) member Yutaka Shikano, Ph.D., recently had research published in Scientific Reports June 20th, 2016

Nanomedicine

Chirality in 'real-time' January 14th, 2019

Ultra-sensitive sensor with gold nanoparticle array January 9th, 2019

Arrowhead Pharmaceuticals Begins Dosing in Phase 1 Study of ARO-ANG3 for Treatment of Dyslipidemias and Metabolic Diseases January 7th, 2019

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1 Study of ARO-APOC3 for Treatment of Hypertriglyceridemia January 7th, 2019

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project